The administration of STING-LNP combined with anti-DP-1 surprisingly generated synergic effects that stimulate NK cell activation and promote the immunosuppressive DP-1/DP-L1 response to B16-F10 melanoma lung metastasis [166]. This evidence concerns the gene STING1 and melanoma.